Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Stony Brook, New York 11794


Purpose:

A study to examine the effect of pioglitazone on the course of new onset type 1 diabetes mellitus.


Study summary:

Thiazolidinediones have been shown to reduce the development of diabetes mellitus in animal models of type 1 diabetes and to reduce the death of beta cells (cells that make insulin) in petri dishes. Pioglitazone is a thiazolidinedione currently approved for the treatment of type 2 diabetes. This study explores the question of whether pioglitazone can preserve beta cell function in patients with recently diagnosed type 1 diabetes mellitus.


Criteria:

Inclusion Criteria: - Patients with type 1 diabetes mellitus diagnosed within 4 months - Age > 6 years of age - Ability to swallow capsule - Signed informed consent / assent Exclusion Criteria: - Other illnesses


NCT ID:

NCT00545857


Primary Contact:

Principal Investigator
Thomas A Wilson, MD
State University of New York, Stony Brook


Backup Contact:

N/A


Location Contact:

Stony Brook, New York 11794
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: August 21, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.